Form 4: Matthew Strobeck, Biodesix Director, Acquires Shares in Recent Transaction

Biodesix Director Matthew Strobeck reports acquisition of common stock through multiple entities, with prices ranging from $1.38 to $1.405.

Summary

• On November 5, 2024, Matthew Strobeck, a director of Biodesix Inc. (BDSX), acquired shares of common stock.
• The transactions involved the purchase of 4,000 shares at a weighted average price of $1.3979 through a Birchview Capital Separately Managed Account.
• Additionally, 36,000 shares were purchased at the same price through Birchview Fund LLC.
• Following these transactions, Strobeck's indirectly held shares through Birchview Capital Separately Managed Account totaled 89,673, and through Birchview Fund LLC, 2,606,879.
• Strobeck also indirectly owns 119,003 shares through a UTMA Account and 40,665 shares through Clajer Capital LLC.
• Strobeck disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard Form 4 filing indicating insider trading activity. The purchase could be seen as slightly positive, but without further context, it's difficult to gauge the overall impact.

Positives

• The director's purchase of shares could be interpreted as a positive signal about the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Comparison to Industry Standards

• Comparing insider transactions to those of peer companies like Exact Sciences (EXAS) or Guardant Health (GH) can provide context.
• For example, similar Form 4 filings from executives at these companies often correlate with significant news or events.
• The size and frequency of insider buys and sells are often compared against industry averages to gauge management's confidence in their respective companies.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive sign.
• The transactions have no immediate impact on employees, customers, suppliers, or creditors.

Key Dates